Committee for Orphan Medicinal Products (COMP): 13-15 February 2024
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
EventHumanRare diseases